[333 Pages Report] With a projected CAGR of 7.4% from 2022 to 2032, the global transcranial doppler ultrasounds system market is anticipated to generate around US$ 658.4 million in sales, up from US$ 299.2 million in 2022. Transcranial doppler ultrasounds system are medically used for quantitative measurement of blood flow velocity of the brain vessels. Transcranial …
Category Archives: Healthcare Trends
3D Medical Implants Market to be valued at US$ 2,494.5 Mn by 2032 | FMI
The three-dimensional (3D) medical implants are medical devices that offer aids in the medical reconstruction procedures of physical faults and abnormalities of the body. The 3D medical implants are commonly additively manufactured using 3D printers; which allow to develop complex geometry features and customized implants specific to the patients’ anatomy. The 3D medical implants technology integrates virtual …
Continue reading “3D Medical Implants Market to be valued at US$ 2,494.5 Mn by 2032 | FMI”
Nasal Packing Devices Market is projected to be valued at about US$ 299.35 Mn by 2032 | FMI
[342 Pages Report] The global nasal packing devices market is expected to reach a market valuation of US$ 182.03 Million by the year 2022, accelerating with a moderate CAGR of 5.1% by 2022-2032. Nasal Packing Devices market size is anticipated to be valued at about US$ 299.35 Million by 2032 end. With more people experiencing epistaxis, there has been …
Autoimmune Disease Therapeutics Market is likely to be valued at US$ 68,410.54 million in 2022 | FMI
[308 Pages Report] Autoimmune Disease Therapeutics Market: Drivers and Restraints Factors contributing to the growth of global autoimmune disease therapeutics market includes, growing prevalence of autoimmune diseases coupled with growing public awareness and increasing automation of laboratories leading to diagnosis of several diagnostic tests simultaneously to generate rapid and error free results. In addition, technological advancements such …
Antisense Oligonucleotides Market is estimated to amass revenue of around US$ 5,659.2 Mn by 2032
[306 Pages Report] The global antisense oligonucleotides market is projected to amass revenue of around US$ 5,659.2 million by 2032, up from US$ 1,921.6 million in 2022 moving forward with a CAGR of 10.3% during the forecast period. Antisense Oligonucleotides market players – Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Inc., Antisense Therapeutics Limited among others represent the global Antisense Oligonucleotides market. …
Angiographic Catheters Market is likely to reach US$ 2,094.4 million by 2032 | FMI
Angiographic Catheters Market Overview Angiographic catheter is used in the angiographic procedures. The angiographic catheters provides therapeutic agents and radiopaque media to the selected sites in vascular system. In addition, the angiographic catheter is also used to lead a guide wire to the targeted site. Angiographic catheters is used for the treatment of cardiac diseases. The thin …
Directed Energy-Based Surgical Systems Market is projected to be valued at US$ 29.58 Bn by 2032
During the projected period, the Directed Energy-Based Surgical Systems Market is expected to grow at a CAGR of 14%. The market is expected to be worth US$ 7.98 billion in 2022, and US$ 29.58 billion by 2032. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI …
Blood Cancer Treatment Market to expand at a 10.2% value CAGR by 2032 | Says FMI Analyst
Global Blood Cancer Treatment Demand (Leukaemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma) is expected to be valued at US$ 5,489.3 million in 2022, rising at a CAGR of 10.2% to US$ 12,943.6 million from 2022 to 2032. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI …
Brain Metastasis Therapeutics is expected to grow at a 7.8% CAGR during the forecast period.
During the forecast period, the Brain Metastasis Therapeutics Market is expected to grow at a 7.8% CAGR. The market is valued at US$ 3079.5226 million in 2022. In 2032, the market is anticipated to be worth US$ 6526.359669 million. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the …
Immunohistochemistry Market | Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation | By 2032
The Immunohistochemistry Market size is expected to be worth US$ 2.05 billion in 2022 and US$ 4.59 billion by 2032, with a quick CAGR of 8.4% between 2022 and 2032. Adoption of immunohistochemistry is anticipated to increase as a result of the rise in healthcare spending and the spike in interest in living a higher quality life. …